====== Medicines for Malaria Venture ====== {{ ::mmv_logo.png?300|}} **Medicines for Malaria Venture (MMV)** is a Swiss non-profit public-private partnership based in [[switzerland:Geneva]], [[Switzerland]]. ===== Organization ===== ==== Funding ==== Current donors to MMV include:((//Current donors.// Medicines for Malaria Venture. Retrieved July 17, 2022, from https://web.archive.org/web/20220717215750/https://www.mmv.org/partnering/our-donors/current-donors)) * [[Australian Government Department of Foreign Affairs and Trade]] * [[Bill & Melinda Gates Foundation]] * [[European and Developing Countries Clinical Trials Partnership]] (EDCTP) * [[German Federal Ministry of Education and Research]] * [[Global Disease Eradication Fund]] * [[Global Health Innovative Technology Fund]] * [[Irish Aid]] * [[KfW]] * [[Korea International Cooperation Agency]] (KOICA) * [[Ministry of Foreign Affairs of the Netherlands]] * [[Newcrest Mining Limited]] * [[Research Investment for Global Health Technology Fund]] * [[Swiss Agency for Development and Cooperation]] (SDC) * [[U.K. Foreign, Commonwealth & Development Office]] * [[Unitaid]] * [[United States Agency for International Development]] (USAID) Former donors include:((//Past donors.// Medicines for Malaria Venture. Retrieved July 17, 2022, from https://archive.ph/jlgTC)) * [[Coordination, Rationalism and Integration of Antimalarial Drug Discovery and Development Initiatives]] (CRIMALDDI) * [[ExxonMobil]] * [[Government of the Principality of Monaco]] * [[pharmaceutical_companies:Johnson & Johnson]] * [[MCJ Amelior Foundation]] * [[National Institutes of Health]] (NIH) * [[Norwegian Agency for Development Cooperation]] (Norad) * [[Rockefeller Foundation]] * [[Spanish Agency for International Cooperation]] * [[Wellcome Trust]] * [[World Bank]] * [[World Health Organization]] ==== Partnerships ==== MMV works with partner clinical sites across the world.((//Clinical centre partners by country.// Medicines for Malaria Venture. Retrieved November 22, 2022, from https://www.mmv.org/partnering/clinical-centre-partners-country)) MMV also collaborates with other organizations developing antimalarial products:((//Other product development partnerships (PDPs).// Medicines for Malaria Venture. Retrieved July 17, 2022, from https://web.archive.org/web/20220717220929/https://www.mmv.org/other-product-development-partnerships-pdps)) * [[Aeras Global TB Vaccine Foundation]] * [[Dengue Vaccine Initiative]] (DVI) * [[Drugs for Neglected Diseases Initiative]] (DNDi) * [[Foundation for Innovative New Diagnostics]] (FIND) * [[Infectious Disease Research Institute]] (IDRI) * [[Innovative Vector Control Consortium]] (IVCC) * [[International AIDS Vaccine Initiative]] (IAVI) * [[International Partnership for Microbicides]] (IPM) * [[International Vaccine Institute]] (IVI) * [[Malaria Control and Evaluation Partnership in Africa]] (MACEPA) at PATH * [[Malaria Vaccine Initiative]] (MVI) * [[Sabin Vaccine Institute]] * [[TB Alliance]]